SPRED1 and Legius syndrome: We have previously demonstrated that SPRED1 overexpression decreased RAS-GTP following EGF stimulation in HEK293T cells and that SPRED1 mutants found in Legius syndrome were unable to decrease RAS-GTP (Stowe et al., 2012).